Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter International Randomized Controlled Trial Comparing Surgical and Medical Therapies in the Treatment of Advanced Metabolic Dysfunction Associated Steatohepatitis

NCT06374875 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT06374875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06374875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter International Randomized Controlled Trial Comparing Surgical and Medical Therapies in the Treatment of Advanced Metabolic Dysfunction Associated Steatohepatitis
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Recruiting
Start date
July 11, 2024
Completion date
December 31, 2029
Enrollment
120 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibrosis, metabolic dysfunction-associated steatohepatitis (mash), metabolic dysfunction-associated steatotic liver disease (masld), non-alcoholic fatty liver disease, obesity